Mirador Capital Partners LP Tenaya Therapeutics, Inc. Transaction History
Mirador Capital Partners LP
- $536 Million
- Q1 2025
A detailed history of Mirador Capital Partners LP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 15,000 shares of TNYA stock, worth $9,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$9,600% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
88Shares Held
43.7MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$6.02 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$4.31 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$3.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$2.09 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $26.5M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...